Sacramento, California 2021-06-08 14:39:22 –
SACRAMENTO (CBS13) – Kaiser Permanente states that the COVID-19 vaccine trial is being extended to children and that some residents of Sacramento can participate.
The exam will consist of 75 children between the ages of 5 and 11 and will also be conducted at the Kaiser Permanente facility in Oakland and Santa Clara, the company said in a press release Tuesday.
Approximately 4,600 children are participating in trials nationwide to evaluate one of the vaccine candidates under development by research sponsors Pfizer, Inc. and BioNTech.
According to Kaiser, this is a randomized trial, with two-thirds of participants receiving the vaccine and one-third receiving the placebo. Neither participants nor clinicians know who is receiving the vaccine or who is receiving the placebo. Data on safety, immune response, and efficacy are collected.
The vaccine has already been given to millions of adults and adolescents aged 12 to 17 years nationwide.
Kaiser Permanente also participated in vaccine trials for adults and 12 to 17 years old.
Kaiser Expands COVID Vaccine Trials To Children; Includes Sacramento – CBS Sacramento Source link Kaiser Expands COVID Vaccine Trials To Children; Includes Sacramento – CBS Sacramento